Novartis AG (SWX:NOVNEE)

Market Cap	219.93B +22.1%
Revenue (ttm)	44.95B +12.9%
Net Income	11.48B -18.2%
EPS	5.82 -14.9%
Shares Out	n/a
PE Ratio	19.16
Forward PE	17.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	180,000
Average Volume	180,000
Open	114.32
Previous Close	114.48
Day's Range	114.14 - 115.24
52-Week Range	81.55 - 116.92
Beta	0.49
RSI	59.58
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: NOVNEE

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD